Brief: United Therapeutics Q3 Revenue USD 748.9 Million Vs. IBES Estimate USD 722.6 Million
30/10/2024 10:30
Oct 30 (Reuters) - United Therapeutics Q3 net income USD 309.1 million
Recent news on United Therapeutics
See all newsBrief: United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
Brief: United Therapeutics Announces FDA Clearance To Proceed With Summit Clinical Trial For Treprostinil Smi In Ph-Copd
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing
Liquidia surges after $381 million settlement with United Therapeutics for lung disease drug